Answers are grounded in this paper and cite their sources.
OBJECTIVE: To describe the use of a 3.5/2.7 mm CastLess Plate (CLP) for pancarpal arthrodesis (PCA) in dogs. STUDY DESIGN: Case series. ANIMALS: Dogs with traumatic/degenerative carpal disease (n=11). METHODS: Records (September 2006-July 2007) of dogs that had PCA using a 3.5/2.7 mm CLP were reviewed to determine intra- and postoperative complications and use of external coaptation. Follow-up (> or =12 months) was obtained by telephone interview of owners. RESULTS: Thirteen PCA procedures were performed; 5 intraoperative complications occurred in 4 procedures and included iatrogenic metacarpal fissure fracture (2), inability to remove an alignment pin (1), and poor distal plate position (2). External coaptation was used in 4 dogs: concomitant or iatrogenic injuries (3), bilateral PCA (1), for 3-6 weeks. Clinical evaluation 6-24 weeks postoperatively revealed iatrogenic metacarpal fractures to have healed and that 1 postoperative complication (infection) developed. Telephone follow-up for 10 dogs (mean, 14 months; range, 12-20 months) revealed no further problems. CONCLUSION: PCA using a 3.5/2.7 mm CLP reduces the need for external coaptation and seemingly reduces postoperative morbidity associated with other internal fixation techniques. CLINICAL RELEVANCE: PCA can be performed safely and successfully using a 3.5/2.7 mm CLP, with low postoperative morbidity compared with other PCA techniques. Particular attention should be taken when applying the distal component of the plate.
No takes yet. Share an insight, caveat, or question.
Clarke et al. (2009) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: